Literature DB >> 21281228

Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia.

Maria L Delioukina, Joycelynne M Palmer, Sandra H Thomas, Amrita Krishnan, Tracey Stiller, Stephen J Forman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21281228      PMCID： PMC3438140          DOI： 10.3109/10428194.2010.541311

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

Authors:  P Dreger; P Corradini; E Kimby; M Michallet; D Milligan; J Schetelig; W Wiktor-Jedrzejczak; D Niederwieser; M Hallek; E Montserrat
Journal:  Leukemia       Date:  2006-11-16       Impact factor: 11.528

2.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

3.  Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

Authors:  J Esteve; N Villamor; D Colomer; F Cervantes; E Campo; E Carreras; E Montserrat
Journal:  Leukemia       Date:  2001-03       Impact factor: 11.528

4.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

5.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

6.  Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.

Authors:  Jennifer R Brown; Haesook T Kim; Shuli Li; Katherine Stephans; David C Fisher; Corey Cutler; Vincent Ho; Stephanie J Lee; Edgar L Milford; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John G Gribben; Edwin P Alyea
Journal:  Biol Blood Marrow Transplant       Date:  2006-10       Impact factor: 5.742

7.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

Authors:  Adrian Wiestner; Andreas Rosenwald; Todd S Barry; George Wright; R Eric Davis; Sarah E Henrickson; Hong Zhao; Rachel E Ibbotson; Jenny A Orchard; Zadie Davis; Maryalice Stetler-Stevenson; Mark Raffeld; Diane C Arthur; Gerald E Marti; Wyndham H Wilson; Terry J Hamblin; David G Oscier; Louis M Staudt
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

8.  Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

Authors:  J Schetelig; C Thiede; M Bornhauser; R Schwerdtfeger; M Kiehl; J Beyer; H G Sayer; N Kroger; M Hensel; C Scheffold; T K Held; K Hoffken; A D Ho; J Kienast; A Neubauer; A R Zander; A A Fauser; G Ehninger; W Siegert
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

9.  HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

Authors:  M Michallet; E Archimbaud; G Bandini; P A Rowlings; H J Deeg; G Gahrton; E Montserrat; C Rozman; A Gratwohl; R P Gale
Journal:  Ann Intern Med       Date:  1996-02-01       Impact factor: 25.391

10.  Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.

Authors:  Johannes Schetelig; Anja van Biezen; Ronald Brand; Dolores Caballero; Rodrigo Martino; Maija Itala; José A García-Marco; Liisa Volin; Norbert Schmitz; Rainer Schwerdtfeger; Arnold Ganser; Francesco Onida; Brigitte Mohr; Stephan Stilgenbauer; Martin Bornhäuser; Theo de Witte; Peter Dreger
Journal:  J Clin Oncol       Date:  2008-08-18       Impact factor: 44.544
View more
  1 in total

Review 1.  Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies.

Authors:  S Fadilah Abdul Wahid
Journal:  Int J Hematol       Date:  2013-04-13       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.